Metabolic engineering of Corynebacterium glutamicum for high-yield de novo biosynthesis of 5-aminovaleramide, a promising bio-based monomer

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Lysine-derived C5 compounds are important intermediates in cellular metabolism and promising building blocks for sustainable polymer chemistry. Among these, 5-aminovalerate (5-AVA) has been extensively studied as a platform chemical produced via a two-step microbial pathway. However, its direct precursor, 5-aminovaleramide (5-AVD), generated from lysine by lysine 2-monooxygenase, remains largely unexplored. Notably, 5-AVD is an attractive product in its own right, as it provides a versatile intermediate for the synthesis of polyamides and other nitrogen-containing chemicals. Here, we establish the first de novo microbial production of 5-AVD by systematically engineering Corynebacterium glutamicum for optimized precursor flux, product export, and redox balance. Results: Trace secretion of 5-AVD was discovered in 5-AVA-producing strains, and tolerance studies showed that C. glutamicum can withstand high 5-AVD concentrations. To exploit this trait, the lysine-producing strain LYS-12 was engineered to express the davB gene from Pseudomonas putida under the constitutive tuf promoter, resulting in increased 5-AVD secretion. Pathway analysis revealed that the native exporter LysE is essential for efficient 5-AVD export, while heterologous GABA permeases provided no benefit. Mechanistic analysis further showed that LysE preferentially exports lysine over 5-AVD, establishing it as a flux gatekeeper that critically shapes product selectivity. Overexpression of heterologous NADP⁺-dependent glyceraldehyde-3-phosphate dehydrogenase (GapN) enhanced NADPH supply and improved redox balance, increasing the 5-AVD yield to 0.32 mol mol−1 in strain AVD-11. In fed-batch fermentation, AVD-11 reached a maximum productivity of 1.2 g L−1 h−1 and a final titer exceeding 36 g L−1 with > 97% selectivity, while chromosomally integrated davB remained genetically stable throughout the process. Conclusions: This study establishes C. glutamicum as a robust and industrially relevant platform for the sustainable production of 5-AVD. By combining rational pathway design, transporter control, and cofactor engineering, we deliver the first high-yield microbial route to this valuable amide and provide a blueprint for expanding the portfolio of lysine-derived monomers accessible through microbial cell factories.

Cite

CITATION STYLE

APA

Sommer, A., Pauli, S., Kohlstedt, M., Becker, J., & Wittmann, C. (2026). Metabolic engineering of Corynebacterium glutamicum for high-yield de novo biosynthesis of 5-aminovaleramide, a promising bio-based monomer. Microbial Cell Factories, 25(1). https://doi.org/10.1186/s12934-026-02922-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free